Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
902 Ergebnisse
| PL1LRT |  | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,229 % | 0,193 | -0,009 | 7,635 | 15.01.2027 | 0,010 | BNP Paribas | |
| PK0DDB | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 73,706 % | 0,176 | -0,027 | 7,181 | 18.09.2026 | 0,010 | BNP Paribas | |
| PK734B | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,308 % | 0,381 | -0,008 | 3,687 | 17.12.2027 | 0,010 | BNP Paribas | |
| PK73H0 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,083 % | 0,245 | -0,009 | 6,302 | 19.03.2027 | 0,010 | BNP Paribas | |
| PK74D1 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,910 % | 0,398 | -0,008 | 3,501 | 21.01.2028 | 0,010 | BNP Paribas | |
| PK75SU | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,134 % | 0,417 | -0,008 | 3,305 | 17.03.2028 | 0,010 | BNP Paribas | |
| PK95YY | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,000 % | 0,448 | -0,008 | 3,009 | 16.06.2028 | 0,010 | BNP Paribas | |
| PM3TL9 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,725 % | 0,316 | -0,010 | 4,924 | 17.06.2027 | 0,010 | BNP Paribas | |
| GJ50FZ | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,712 % | 0,101 | -0,013 | 11,236 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GU9H3U | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,090 % | 0,172 | -0,009 | 7,549 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW1J0H | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,565 % | 0,366 | -0,008 | 3,862 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K3Z | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,264 % | 0,358 | -0,009 | 4,228 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4M | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,049 % | 0,411 | -0,008 | 3,576 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K6Z | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,565 % | 0,366 | -0,008 | 3,862 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8E | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,895 % | 0,308 | -0,009 | 5,053 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW43BC | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,758 % | 0,214 | -0,008 | 6,443 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW75RD | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 67,355 % | 0,085 | -0,019 | 11,999 | 21.08.2026 | 0,010 | Goldman Sachs | ||
| GW75R6 | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,083 % | 0,163 | -0,010 | 7,740 | 18.12.2026 | 0,010 | Goldman Sachs | ||
| GW8VQ4 | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,373 % | 0,424 | -0,007 | 3,273 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW9AK2 | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | 1.100,000 | 33,629 % | - | - | - | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW9D3E | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,499 % | 0,122 | -0,008 | 10,213 | 20.11.2026 | 0,010 | Goldman Sachs | ||
| GN07V2 | Regeneron Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,317 % | 0,078 | -0,007 | 11,700 | 16.10.2026 | 0,010 | Goldman Sachs | ||
| MJ474E | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,773 % | 0,160 | -0,009 | 7,817 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM5GZ0 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 55,603 % | 0,125 | -0,016 | 9,887 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MM7L6S | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,049 % | 0,293 | -0,009 | 4,915 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MN04N9 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,009 % | 0,399 | -0,009 | 3,458 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN1W0Y | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | 950,000 | 75,055 % | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN6F4C | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,505 % | 0,237 | -0,009 | 5,915 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MN8XDR | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | 950,000 | 77,548 % | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MN8XDP | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | 950,000 | - | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN8XDQ | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | 950,000 | 91,269 % | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR3CF7 | | Regeneron Pharmaceuticals Inc./OS/Call [900]/MS | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 49,138 % | 0,479 | -0,009 | 2,711 | 16.06.2028 | 0,010 | Morgan Stanley | |
| SX5KRB | Regeneron Pharmaceuticals Inc./OS/Call [900]/SOC | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,063 % | 0,046 | -0,052 | 15,987 | 18.09.2026 | 0,100 | Société Générale | ||
| FD442K | Regeneron Pharmaceuticals Inc./OS/Call [900]/SOC | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,882 % | 0,124 | -0,070 | 9,209 | 18.12.2026 | 0,100 | Société Générale | ||
| FD48PB | Regeneron Pharmaceuticals Inc./OS/Call [900]/SOC | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,536 % | 0,196 | -0,075 | 6,942 | 19.03.2027 | 0,100 | Société Générale | ||
| FD51EW | Regeneron Pharmaceuticals Inc./OS/Call [900]/SOC | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 34,483 % | 0,237 | -0,069 | 6,046 | 17.06.2027 | 0,100 | Société Générale | ||
| FE23H9 | Regeneron Pharmaceuticals Inc./OS/Call [900]/SOC | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,116 % | 0,370 | -0,076 | 3,858 | 21.01.2028 | 0,100 | Société Générale | ||
| VJ2MGK | | Regeneron Pharmaceuticals Inc./OS/Call [900]/VONT | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,156 % | 0,126 | -0,007 | 9,118 | 18.12.2026 | 0,010 | Vontobel | |
| VJ2MGY | | Regeneron Pharmaceuticals Inc./OS/Call [900]/VONT | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,116 % | 0,147 | -0,007 | 8,378 | 15.01.2027 | 0,010 | Vontobel | |
| MJ5C6W | | Regeneron Pharmaceuticals Inc./OS/Call [925]/MS | - | - | 925,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,828 % | 0,140 | -0,009 | 8,052 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM8YT1 | | Regeneron Pharmaceuticals Inc./OS/Call [925]/MS | - | - | 925,000 | call | Regeneron Pharmaceuticals Inc. | - | 63,523 % | 0,113 | -0,017 | 9,015 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MM8Z6L | | Regeneron Pharmaceuticals Inc./OS/Call [925]/MS | - | - | 925,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,021 % | 0,298 | -0,009 | 4,885 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MN1HGV | | Regeneron Pharmaceuticals Inc./OS/Call [925]/MS | - | - | 925,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,927 % | 0,378 | -0,009 | 3,532 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6F4D | | Regeneron Pharmaceuticals Inc./OS/Call [925]/MS | - | - | 925,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,943 % | 0,216 | -0,009 | 6,011 | 19.03.2027 | 0,010 | Morgan Stanley | |
| GJ50FU | Regeneron Pharmaceuticals Inc./OS/Call [950]/GOLDS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 63,340 % | 0,088 | -0,014 | 9,470 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GW3WD1 | Regeneron Pharmaceuticals Inc./OS/Call [950]/GOLDS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,258 % | 0,136 | -0,008 | 7,756 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW4K10 | Regeneron Pharmaceuticals Inc./OS/Call [950]/GOLDS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,886 % | 0,167 | -0,007 | 6,823 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW92TL | Regeneron Pharmaceuticals Inc./OS/Call [950]/GOLDS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,143 % | 0,240 | -0,008 | 5,650 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| MJ5C6X | | Regeneron Pharmaceuticals Inc./OS/Call [950]/MS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,484 % | 0,090 | -0,006 | 9,670 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM7L6T | | Regeneron Pharmaceuticals Inc./OS/Call [950]/MS | - | - | 950,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,633 % | 0,255 | -0,009 | 5,054 | 17.06.2027 | 0,010 | Morgan Stanley |